Squarepoint’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Squarepoint’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-59	Closed	-$9K	–	1969
2017 Q2	$9K	Buy	+59	New	+$11.9K	﹤0.01%	1494

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

GIA

GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Squarepoint's AMPE Position: Q3 2017 in Review

Squarepoint sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2017, closing a stake of 59 shares — an estimated $9K sold.

Squarepoint first reported a position in AMPE in Q2 2017 and held it in 1 quarter. The position peaked at $9K in Q2 2017. 45 funds tracked by Wall St. Rank hold AMPE as of Q3 2017.

Squarepoint reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
Squarepoint sold 59 Ampio Pharmaceuticals Inc. shares in Q3 2017, an estimated $9K.
Squarepoint first reported a position in Ampio Pharmaceuticals Inc. in Q2 2017 and held it in 1 quarter.
Squarepoint's Ampio Pharmaceuticals Inc. position peaked at $9K in Q2 2017.
45 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2017.

Based on Squarepoint's 13F filing for Q3 2017, filed 14 Nov 2017.